Cataract Surgery · Surgeon Series
The lens wobbles.
The plan changes.
Mid-case.
Phacodonesis on the table. Pseudoexfoliation flakes catching the light on the pupil margin. A capsulorhexis that wants to run radially instead of curving. These are the moments a routine cataract case becomes a zonular-weakness case, and the capsular tension ring is the device most surgeons reach for first — but only 0.94% of cases actually need one, and knowing exactly when is a real, evidence-backed decision, not a reflex.
needed a CTR
mature cataract, not PXF
late vs early insertion
Section 01 — What It Actually Does
A ring doesn't fix
weak zonules.
It redistributes them.
The single most common misunderstanding about a capsular tension ring is what it is actually for. It does not strengthen, repair, or replace damaged zonular fibers.
A capsular tension ring (CTR) is an open, flexible PMMA ring, implanted inside the capsular bag — typically after the capsulorhexis, before or during nucleus removal. Once seated, it presses outward against the equator of the bag from the inside, and because it is a continuous circle, any mechanical stress applied anywhere on the bag during phacoemulsification, cortex aspiration or IOL insertion gets distributed around the entire circumference rather than concentrating on whichever sector of zonules is already weakest. It keeps the bag round and open. It does not, on its own, provide any fixation to the sclera — it works only if enough intact zonular support remains to hold the ring, and by extension the bag, roughly in place.
A capsular tension ring is an open PMMA ring implanted in the capsular bag that redistributes surgical stress evenly around the zonules instead of concentrating it on a weak sector, and helps the bag stay round rather than collapsing. It does not repair zonules and provides no scleral fixation on its own — severe or progressive zonular loss needs a fixation-capable device instead, such as a modified CTR with eyelets or a capsular tension segment. In a review of 4,316 cataract surgeries, a CTR was used in only 0.94% of cases, most often for mature cataracts requiring more mechanical force to remove, ahead of pseudoexfoliation syndrome, trauma, retinitis pigmentosa and degenerative myopia.
Section 02 — Interactive
Why a CTR gets used
isn't what
most surgeons expect.
Pseudoexfoliation syndrome is the condition most associated with capsular tension rings in surgical teaching. In a real 4,316-case review, it was only the third most common reason one was actually needed. Select each indication below to see its real share.
Mature cataracts — dense, often long-neglected lenses requiring substantially more mechanical force and manipulation to remove — were the single largest reason a CTR was needed in this series, ahead of both trauma and pseudoexfoliation. The likely mechanism is straightforward: harder nuclei need more rotational and aspiration force, and that force finds and exploits any pre-existing zonular weakness that a softer, earlier-stage cataract might never have stressed enough to reveal.
Section 03 — The Randomized Evidence
What a CTR
measurably changes,
and what it doesn't.
Beyond intraoperative handling, does a CTR actually change measurable postoperative outcomes? A randomized controlled trial comparing CTR and non-CTR groups in eyes with weak zonules gives a real, numeric answer.
At three months postoperatively, capsulorhexis area was significantly larger and more stable in the CTR group (21.53±3.47mm²) than in the control group (18.76±3.93mm², p=0.0199) — and the gap was even wider in the high-myopia subgroup (22.48±3.71mm² vs 16.97±5.03mm², p=0.0113). Control eyes also showed measurably increasing IOL tilt over time, from 0.73° at one week to 1.84° by three months (p=0.0224), while CTR eyes stayed stable across the same period. At one week, posterior capsule adhesion was complete in 54.5% of CTR eyes versus only 20.0% of control eyes (p=0.023).
Illustrative visualisation of the direction and relative magnitude reported in the cited RCT — see References for the source study and exact figures.
The honest, complete picture: a CTR measurably improves capsular bag stability, IOL centration and posterior capsule adhesion in eyes with weak zonules. It does not, in this trial, improve refractive predictability — the final refractive outcome was not significantly different between groups. A CTR is a mechanical stability device, not a biometry or power-calculation aid, and it should be counseled that way.
Section 04 — The Timing Debate
Early or late?
Both have a real,
documented cost.
Once the decision to use a CTR is made, a second, genuinely unresolved question follows immediately: insert it before nucleus removal, or after? The published evidence shows a real trade-off, not a clearly correct default.
| Timing | Documented advantage | Documented cost |
|---|---|---|
| Early (before nucleus removal) | Supports the weak zonular area through the most mechanically stressful steps of surgery | Cortex removal significantly more difficult (p=0.003); 9.5% incidence of clinically significant zonular dialysis extension in one study |
| Late (after nucleus & cortex removal) | Nucleus and cortex removed without becoming trapped between ring and capsule; easier cortex removal | Posterior capsule fluctuations in 29.5% of cases, causing rupture in 2 patients; higher overall intraoperative complication rate (40.7% vs 18.7%) |
Neither timing eliminated IOL decentration risk outright — only 6.5% of early-insertion eyes and 7.4% of late-insertion eyes in the same series needed ciliary sulcus placement instead of in-the-bag fixation, a small and statistically similar minority either way. CTR insertion difficulty itself did not differ significantly by timing (p=0.124). What differed was where the risk showed up: early insertion traded harder cortex removal and a real zonular-dialysis-extension risk for zonular protection during the case; late insertion traded easier cortex removal for a higher rate of posterior capsule complications, including rupture.
Section 05 — Recognizing It in Time
The signs that
should change
the surgical plan.
A CTR is most useful when it is planned for, or at least anticipated, rather than reached for in the middle of an unexpected complication. Recognizing zonular weakness starts before the first incision.
Not every case gives a clean preoperative warning. Mature, densely brunescent cataracts — the single largest real-world indication in the 4,316-case series — often show no obvious phacodonesis or pseudoexfoliation signs beforehand, and the zonular stress only becomes apparent once significant rotational force is already being applied. This is the practical argument for having a CTR immediately available for any dense, long-standing cataract, not reserving it mentally for pseudoexfoliation cases alone.
Section 06 — When a Plain Ring Isn't Enough
Beyond the CTR:
segments, hooks,
and real fixation.
A standard CTR assumes enough intact zonular support remains to hold the ring in place on its own. When that assumption fails, the device needs to change, not just the technique.
When zonular loss is extensive — commonly cited thresholds in the literature are roughly a third or more of the circumference, though surgeon judgment and progression matter as much as any fixed number — a plain CTR alone cannot provide the scleral anchoring the eye now needs, because a plain CTR has no fixation point at all. In these cases, surgeons typically move to a modified capsular tension ring with fixation eyelets, or a capsular tension segment (sometimes referred to by the eponym Cionni ring), which can be sutured or otherwise fixated directly to the sclera. This provides genuine mechanical anchoring rather than only stress redistribution, at the cost of a more involved, longer surgery with its own separate complication profile.
| Device | Provides scleral fixation? | Typical use case |
|---|---|---|
| Standard CTR | No | Zonular weakness with substantial intact zonular support remaining; distributes stress, no anchoring needed |
| Modified CTR (with eyelets) | Yes, via the eyelet(s) | More significant, focal zonular loss where some additional anchoring is prudent but a full segment isn't necessary |
| Capsular tension segment / Cionni ring | Yes, direct scleral suture fixation | Extensive or progressive zonular loss, subluxated lens, or eyes at high risk of progressive zonulopathy over time |
Choosing between these three is itself one of the more consequential intraoperative decisions in a zonular-weakness case, and getting it wrong in either direction has real costs — under-treating a severely compromised eye with a plain CTR risks late in-the-bag IOL subluxation years after an apparently uneventful surgery, while over-treating a mild case adds unnecessary surgical time and complexity.
Section 07 — In the Operating Room
A mature cataract
with no warning
signs beforehand.
The 4,316-case data point that mature cataracts, not pseudoexfoliation, are the leading real-world reason for a CTR plays out concretely in cases like this one.
A patient presents with a markedly brunescent, mature cataract that has gone untreated for years due to limited access to care. Preoperative slit-lamp exam shows no phacodonesis, no visible pseudoexfoliation material, and a normal anterior chamber depth — nothing that would have flagged a zonular concern on the surgical consent. During phacoemulsification, the increased rotational force required to manipulate the dense nucleus begins to visibly stress one quadrant of zonules, with subtle capsular bag mobility noted by the surgeon. A CTR is inserted after nucleus removal is completed, prioritizing easier cortex aspiration given the case is already underway, accepting the documented trade-off of a higher posterior capsule fluctuation risk with late insertion in exchange for not complicating an already technically demanding nuclear removal.
The case underlines why "watch for pseudoexfoliation" is an incomplete screening heuristic on its own. The single most common real-world trigger for needing a CTR was not a rare syndrome with obvious external signs — it was simply a very hard cataract, the kind any high-volume surgical practice sees routinely.
Section 08 — The Agaaz Role
Same procedure,
same intraoperative
fundamentals.
Agaaz Ophthalmics does not manufacture capsular tension rings. The intraocular case built around any zonular-weakness cataract surgery — chamber stability during a technically demanding case, capsule visualization, and infection prophylaxis at close — is the same territory Agaaz supplies for cataract surgery generally, and it matters more, not less, in exactly these harder cases.
Trypan blue capsule staining is covered in more depth in the Trypan Blue in Cataract Surgery guide. View the complete portfolio →
Section 09 — FAQ
Frequently asked questions
about capsular tension rings.
A capsular tension ring (CTR) is an open, flexible PMMA ring implanted inside the capsular bag, typically after the capsulorhexis and before or during nucleus removal. It does not repair or strengthen weak zonules directly. Instead, it distributes mechanical stress evenly around the full circumference of the capsular bag, so that surgical forces during phacoemulsification are no longer concentrated on the weakest sector of zonules, and it helps keep the bag open and round rather than collapsing toward the area of weakness. Randomized evidence shows CTR eyes maintain a significantly more stable capsulorhexis area and more stable IOL inclination over the first 3 postoperative months than eyes without one.
Preoperative clues include phacodonesis (a visible wobble of the lens with eye movement), iridodonesis, an asymmetric or unusually deep anterior chamber, visible pseudoexfoliation material on the pupil margin or lens surface, a history of trauma, high myopia, or a known connective tissue condition such as Marfan syndrome. Intraoperatively, a capsulorhexis that tears radially instead of curving, unusual capsular bag mobility, or visible zonular fibers stretching or snapping during rotation are all signs surgeons watch for, sometimes only becoming apparent once surgery is already underway.
In a published review of 4,316 consecutive cataract surgeries at a tertiary teaching hospital, a CTR was used in only 41 eyes — about 0.94% of all cases — but the breakdown of why it was needed is instructive: zonular weakness associated with mature cataract accounted for 29.2% of CTR cases, trauma 24.3%, pseudoexfoliation syndrome 19.5%, retinitis pigmentosa 14.6%, degenerative myopia 9.7%, and lens coloboma 2.4%. Mature, dense cataracts requiring more mechanical force to remove were actually the single largest reason a CTR was needed, ahead of pseudoexfoliation, the condition most commonly associated with the device in surgical teaching.
This remains genuinely debated, with a real trade-off rather than a clearly correct answer. Early insertion, before nucleus removal, supports the weak zonular area throughout the most mechanically stressful steps of surgery, but one study found it made cortex removal significantly more difficult and reported a 9.5% incidence of clinically significant extension of zonular dialysis with early placement. Late insertion, after nucleus and cortex removal, made cortex removal easier but was associated with posterior capsule fluctuations in 29.5% of cases in the same study, causing frank rupture in two patients, and a higher overall intraoperative complication rate (40.7% versus 18.7% for early insertion). Surgeons weigh this risk-to-benefit trade-off case by case rather than following one fixed rule.
No, and this is a common misunderstanding. A standard CTR redistributes stress across intact, but weakened, zonular support — it is not a fixation device and provides no attachment to the sclera. When zonular loss is severe, progressive, or covers more than roughly a third of the circumference, surgeons typically move to a modified capsular tension ring with fixation eyelets, or a capsular tension segment (sometimes called a Cionni ring), which can be sutured or otherwise fixated to the sclera to provide the scleral anchoring a plain CTR cannot. Choosing between a plain CTR and a fixation-capable device is itself a key intraoperative decision in significant zonulopathy.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Cataract Surgery · Surgeon Series
The lens wobbles.
The plan changes.
Mid-case.
Phacodonesis on the table. Pseudoexfoliation flakes catching the light on the pupil margin. A capsulorhexis that wants to run radially instead of curving. These are the moments a routine cataract case becomes a zonular-weakness case, and the capsular tension ring is the device most surgeons reach for first — but only 0.94% of cases actually need one, and knowing exactly when is a real, evidence-backed decision, not a reflex.
needed a CTR
mature cataract, not PXF
late vs early insertion
Section 01 — What It Actually Does
A ring doesn't fix
weak zonules.
It redistributes them.
The single most common misunderstanding about a capsular tension ring is what it is actually for. It does not strengthen, repair, or replace damaged zonular fibers.
A capsular tension ring (CTR) is an open, flexible PMMA ring, implanted inside the capsular bag — typically after the capsulorhexis, before or during nucleus removal. Once seated, it presses outward against the equator of the bag from the inside, and because it is a continuous circle, any mechanical stress applied anywhere on the bag during phacoemulsification, cortex aspiration or IOL insertion gets distributed around the entire circumference rather than concentrating on whichever sector of zonules is already weakest. It keeps the bag round and open. It does not, on its own, provide any fixation to the sclera — it works only if enough intact zonular support remains to hold the ring, and by extension the bag, roughly in place.
A capsular tension ring is an open PMMA ring implanted in the capsular bag that redistributes surgical stress evenly around the zonules instead of concentrating it on a weak sector, and helps the bag stay round rather than collapsing. It does not repair zonules and provides no scleral fixation on its own — severe or progressive zonular loss needs a fixation-capable device instead, such as a modified CTR with eyelets or a capsular tension segment. In a review of 4,316 cataract surgeries, a CTR was used in only 0.94% of cases, most often for mature cataracts requiring more mechanical force to remove, ahead of pseudoexfoliation syndrome, trauma, retinitis pigmentosa and degenerative myopia.
Section 02 — Interactive
Why a CTR gets used
isn't what
most surgeons expect.
Pseudoexfoliation syndrome is the condition most associated with capsular tension rings in surgical teaching. In a real 4,316-case review, it was only the third most common reason one was actually needed. Select each indication below to see its real share.
Mature cataracts — dense, often long-neglected lenses requiring substantially more mechanical force and manipulation to remove — were the single largest reason a CTR was needed in this series, ahead of both trauma and pseudoexfoliation. The likely mechanism is straightforward: harder nuclei need more rotational and aspiration force, and that force finds and exploits any pre-existing zonular weakness that a softer, earlier-stage cataract might never have stressed enough to reveal.
Section 03 — The Randomized Evidence
What a CTR
measurably changes,
and what it doesn't.
Beyond intraoperative handling, does a CTR actually change measurable postoperative outcomes? A randomized controlled trial comparing CTR and non-CTR groups in eyes with weak zonules gives a real, numeric answer.
At three months postoperatively, capsulorhexis area was significantly larger and more stable in the CTR group (21.53±3.47mm²) than in the control group (18.76±3.93mm², p=0.0199) — and the gap was even wider in the high-myopia subgroup (22.48±3.71mm² vs 16.97±5.03mm², p=0.0113). Control eyes also showed measurably increasing IOL tilt over time, from 0.73° at one week to 1.84° by three months (p=0.0224), while CTR eyes stayed stable across the same period. At one week, posterior capsule adhesion was complete in 54.5% of CTR eyes versus only 20.0% of control eyes (p=0.023).
Illustrative visualisation of the direction and relative magnitude reported in the cited RCT — see References for the source study and exact figures.
The honest, complete picture: a CTR measurably improves capsular bag stability, IOL centration and posterior capsule adhesion in eyes with weak zonules. It does not, in this trial, improve refractive predictability — the final refractive outcome was not significantly different between groups. A CTR is a mechanical stability device, not a biometry or power-calculation aid, and it should be counseled that way.
Section 04 — The Timing Debate
Early or late?
Both have a real,
documented cost.
Once the decision to use a CTR is made, a second, genuinely unresolved question follows immediately: insert it before nucleus removal, or after? The published evidence shows a real trade-off, not a clearly correct default.
| Timing | Documented advantage | Documented cost |
|---|---|---|
| Early (before nucleus removal) | Supports the weak zonular area through the most mechanically stressful steps of surgery | Cortex removal significantly more difficult (p=0.003); 9.5% incidence of clinically significant zonular dialysis extension in one study |
| Late (after nucleus & cortex removal) | Nucleus and cortex removed without becoming trapped between ring and capsule; easier cortex removal | Posterior capsule fluctuations in 29.5% of cases, causing rupture in 2 patients; higher overall intraoperative complication rate (40.7% vs 18.7%) |
Neither timing eliminated IOL decentration risk outright — only 6.5% of early-insertion eyes and 7.4% of late-insertion eyes in the same series needed ciliary sulcus placement instead of in-the-bag fixation, a small and statistically similar minority either way. CTR insertion difficulty itself did not differ significantly by timing (p=0.124). What differed was where the risk showed up: early insertion traded harder cortex removal and a real zonular-dialysis-extension risk for zonular protection during the case; late insertion traded easier cortex removal for a higher rate of posterior capsule complications, including rupture.
Section 05 — Recognizing It in Time
The signs that
should change
the surgical plan.
A CTR is most useful when it is planned for, or at least anticipated, rather than reached for in the middle of an unexpected complication. Recognizing zonular weakness starts before the first incision.
Not every case gives a clean preoperative warning. Mature, densely brunescent cataracts — the single largest real-world indication in the 4,316-case series — often show no obvious phacodonesis or pseudoexfoliation signs beforehand, and the zonular stress only becomes apparent once significant rotational force is already being applied. This is the practical argument for having a CTR immediately available for any dense, long-standing cataract, not reserving it mentally for pseudoexfoliation cases alone.
Section 06 — When a Plain Ring Isn't Enough
Beyond the CTR:
segments, hooks,
and real fixation.
A standard CTR assumes enough intact zonular support remains to hold the ring in place on its own. When that assumption fails, the device needs to change, not just the technique.
When zonular loss is extensive — commonly cited thresholds in the literature are roughly a third or more of the circumference, though surgeon judgment and progression matter as much as any fixed number — a plain CTR alone cannot provide the scleral anchoring the eye now needs, because a plain CTR has no fixation point at all. In these cases, surgeons typically move to a modified capsular tension ring with fixation eyelets, or a capsular tension segment (sometimes referred to by the eponym Cionni ring), which can be sutured or otherwise fixated directly to the sclera. This provides genuine mechanical anchoring rather than only stress redistribution, at the cost of a more involved, longer surgery with its own separate complication profile.
| Device | Provides scleral fixation? | Typical use case |
|---|---|---|
| Standard CTR | No | Zonular weakness with substantial intact zonular support remaining; distributes stress, no anchoring needed |
| Modified CTR (with eyelets) | Yes, via the eyelet(s) | More significant, focal zonular loss where some additional anchoring is prudent but a full segment isn't necessary |
| Capsular tension segment / Cionni ring | Yes, direct scleral suture fixation | Extensive or progressive zonular loss, subluxated lens, or eyes at high risk of progressive zonulopathy over time |
Choosing between these three is itself one of the more consequential intraoperative decisions in a zonular-weakness case, and getting it wrong in either direction has real costs — under-treating a severely compromised eye with a plain CTR risks late in-the-bag IOL subluxation years after an apparently uneventful surgery, while over-treating a mild case adds unnecessary surgical time and complexity.
Section 07 — In the Operating Room
A mature cataract
with no warning
signs beforehand.
The 4,316-case data point that mature cataracts, not pseudoexfoliation, are the leading real-world reason for a CTR plays out concretely in cases like this one.
A patient presents with a markedly brunescent, mature cataract that has gone untreated for years due to limited access to care. Preoperative slit-lamp exam shows no phacodonesis, no visible pseudoexfoliation material, and a normal anterior chamber depth — nothing that would have flagged a zonular concern on the surgical consent. During phacoemulsification, the increased rotational force required to manipulate the dense nucleus begins to visibly stress one quadrant of zonules, with subtle capsular bag mobility noted by the surgeon. A CTR is inserted after nucleus removal is completed, prioritizing easier cortex aspiration given the case is already underway, accepting the documented trade-off of a higher posterior capsule fluctuation risk with late insertion in exchange for not complicating an already technically demanding nuclear removal.
The case underlines why "watch for pseudoexfoliation" is an incomplete screening heuristic on its own. The single most common real-world trigger for needing a CTR was not a rare syndrome with obvious external signs — it was simply a very hard cataract, the kind any high-volume surgical practice sees routinely.
Section 08 — The Agaaz Role
Same procedure,
same intraoperative
fundamentals.
Agaaz Ophthalmics does not manufacture capsular tension rings. The intraocular case built around any zonular-weakness cataract surgery — chamber stability during a technically demanding case, capsule visualization, and infection prophylaxis at close — is the same territory Agaaz supplies for cataract surgery generally, and it matters more, not less, in exactly these harder cases.
Trypan blue capsule staining is covered in more depth in the Trypan Blue in Cataract Surgery guide. View the complete portfolio →
Section 09 — FAQ
Frequently asked questions
about capsular tension rings.
A capsular tension ring (CTR) is an open, flexible PMMA ring implanted inside the capsular bag, typically after the capsulorhexis and before or during nucleus removal. It does not repair or strengthen weak zonules directly. Instead, it distributes mechanical stress evenly around the full circumference of the capsular bag, so that surgical forces during phacoemulsification are no longer concentrated on the weakest sector of zonules, and it helps keep the bag open and round rather than collapsing toward the area of weakness. Randomized evidence shows CTR eyes maintain a significantly more stable capsulorhexis area and more stable IOL inclination over the first 3 postoperative months than eyes without one.
Preoperative clues include phacodonesis (a visible wobble of the lens with eye movement), iridodonesis, an asymmetric or unusually deep anterior chamber, visible pseudoexfoliation material on the pupil margin or lens surface, a history of trauma, high myopia, or a known connective tissue condition such as Marfan syndrome. Intraoperatively, a capsulorhexis that tears radially instead of curving, unusual capsular bag mobility, or visible zonular fibers stretching or snapping during rotation are all signs surgeons watch for, sometimes only becoming apparent once surgery is already underway.
In a published review of 4,316 consecutive cataract surgeries at a tertiary teaching hospital, a CTR was used in only 41 eyes — about 0.94% of all cases — but the breakdown of why it was needed is instructive: zonular weakness associated with mature cataract accounted for 29.2% of CTR cases, trauma 24.3%, pseudoexfoliation syndrome 19.5%, retinitis pigmentosa 14.6%, degenerative myopia 9.7%, and lens coloboma 2.4%. Mature, dense cataracts requiring more mechanical force to remove were actually the single largest reason a CTR was needed, ahead of pseudoexfoliation, the condition most commonly associated with the device in surgical teaching.
This remains genuinely debated, with a real trade-off rather than a clearly correct answer. Early insertion, before nucleus removal, supports the weak zonular area throughout the most mechanically stressful steps of surgery, but one study found it made cortex removal significantly more difficult and reported a 9.5% incidence of clinically significant extension of zonular dialysis with early placement. Late insertion, after nucleus and cortex removal, made cortex removal easier but was associated with posterior capsule fluctuations in 29.5% of cases in the same study, causing frank rupture in two patients, and a higher overall intraoperative complication rate (40.7% versus 18.7% for early insertion). Surgeons weigh this risk-to-benefit trade-off case by case rather than following one fixed rule.
No, and this is a common misunderstanding. A standard CTR redistributes stress across intact, but weakened, zonular support — it is not a fixation device and provides no attachment to the sclera. When zonular loss is severe, progressive, or covers more than roughly a third of the circumference, surgeons typically move to a modified capsular tension ring with fixation eyelets, or a capsular tension segment (sometimes called a Cionni ring), which can be sutured or otherwise fixated to the sclera to provide the scleral anchoring a plain CTR cannot. Choosing between a plain CTR and a fixation-capable device is itself a key intraoperative decision in significant zonulopathy.
References & Evidence Base
Peer-reviewed
citations.
Continue Reading
Related guides
from Beyond Vision.
Start writing here...
Capsular Tension Rings: When Zonular Weakness Changes the Surgical Plan